Redcentric Salute del bilancio

Salute finanziaria criteri di controllo 1/6

Redcentric ha un patrimonio netto totale di £56.8M e un debito totale di £42.7M, che porta il suo rapporto debito/patrimonio netto a 75.3%. Le sue attività totali e le sue passività totali sono rispettivamente £181.0M e £124.2M. L'EBIT di Redcentric è £8.7M rendendo il suo rapporto di copertura degli interessi 1.5. Ha liquidità e investimenti a breve termine pari a £4.0M.

Informazioni chiave

75.3%

Rapporto debito/patrimonio netto

UK£42.74m

Debito

Indice di copertura degli interessi	1.5x
Contanti	UK£4.00m
Patrimonio netto	UK£56.77m
Totale passività	UK£124.20m
Totale attività	UK£180.96m

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Redcentric plc's (LON:RCN) Price In Tune With Revenues

May 21

Some Confidence Is Lacking In Redcentric plc's (LON:RCN) P/E

Sep 21

Redcentric plc's (LON:RCN) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 03

An Intrinsic Calculation For Redcentric plc (LON:RCN) Suggests It's 26% Undervalued

Jan 18

Have Insiders Been Selling Redcentric plc (LON:RCN) Shares This Year?

Dec 14

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( { RCN di £42.8M ) non coprono le sue passività a breve termine ( £52.3M ).

Passività a lungo termine: Le attività a breve termine di RCN ( £42.8M ) non coprono le sue passività a lungo termine ( £71.8M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 68.2% ) di RCN è considerato alto.

Riduzione del debito: Il rapporto debito/patrimonio netto di RCN è aumentato da 17.6% a 75.3% negli ultimi 5 anni.

Copertura del debito: Il debito di RCN è ben coperto dal flusso di cassa operativo ( 70.8% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di RCN non sono ben coperti dall'EBIT ( 1.5 x copertura).

Redcentric Salute del bilancio

Salute finanziaria criteri di controllo 1/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Recent updates

First half 2025 earnings released: EPS: UK£0.024 (vs UK£0.001 loss in 1H 2024)

First half dividend of UK£0.024 announced

New major risk - Financial position

Redcentric plc Announces Intention to Pay Interim Dividend, Payable on 25 April 2025

High number of new directors

Redcentric plc Appoints John Radziwill as Non-Executive Director

Redcentric plc Announces Board Changes

CEO & Executive Director exercised options and sold UK£92k worth of stock

Full year 2024 earnings released: UK£0.022 loss per share (vs UK£0.059 loss in FY 2023)

Redcentric plc Recommends Final Dividend for 2024, Expects to Be Paid on 24 January 2025

Redcentric plc Announces Company Secretary Changes

New minor risk - Financial data availability

Redcentric Confirms Early Stages of Discussions with Wiit Regarding a Possible Offer for the Entire Issued and to be Issued Share Capital of Redcentric

Redcentric plc's (LON:RCN) Price In Tune With Revenues

Redcentric plc, Annual General Meeting, Sep 18, 2024

Upcoming dividend of UK£0.012 per share

Redcentric plc Appoints Michelle Senecal De Fonseca as Non-Executive Director, Chair of the Remuneration Committee and Member of the Audit and Nomination Committees

Less than half of directors are independent

Upcoming dividend of UK£0.024 per share at 2.9% yield

First half 2024 earnings released: UK£0.001 loss per share (vs UK£0.039 loss in 1H 2023)

Redcentric plc Declares Interim Dividend for the Six Months Ended 30 September 2023, Payable on 18 April 2024

Redcentric plc Recommends Final Dividend for the Year 2023, Payable on January 19, 2024

Redcentric plc to Report Fiscal Year 2023 Results on Aug 24, 2023

Redcentric plc Reiterates Earnings Guidance for the Fiscal Year 2023

New minor risk - Financial data availability

Consensus forecasts updated

Redcentric plc to Report First Half, 2024 Results on Nov 22, 2023

First half 2023 earnings released: EPS: UK£0.023 (vs UK£0.018 in 1H 2022)

Redcentric plc Announces an Interim Dividend, Payable on 27 January 2023

Consensus forecasts updated

High number of new and inexperienced directors

Redcentric plc Provides Earnings Guidance for the Year 2023

Some Confidence Is Lacking In Redcentric plc's (LON:RCN) P/E

High number of new and inexperienced directors

Consensus forecasts updated

Full year 2022 earnings released: EPS: UK£0.044 (vs UK£0.06 in FY 2021)

Redcentric plc Recommends Final Dividend for the Fiscal Year 2022, Payable on September 16, 2022

Redcentric plc Announces Management Changes

High number of new and inexperienced directors

CEO & Executive Director exercised options and sold UK£255k worth of stock

First half 2022 earnings released: EPS UK£0.017 (vs UK£0.014 in 1H 2021)

Redcentric plc's (LON:RCN) CEO Compensation Is Looking A Bit Stretched At The Moment

Redcentric's (LON:RCN) Earnings Are Of Questionable Quality

Upcoming dividend of UK£0.024 per share

Estimating The Fair Value Of Redcentric plc (LON:RCN)

Senior Independent Non-Executive Director has left the company

What Kind Of Investors Own Most Of Redcentric plc (LON:RCN)?

An Intrinsic Calculation For Redcentric plc (LON:RCN) Suggests It's 26% Undervalued

CEO & Executive Director exercised options and sold UK£107k worth of stock

Redcentric plc has completed a Follow-on Equity Offering in the amount of £38.5 million.

New 90-day low: UK£1.19

Have Insiders Been Selling Redcentric plc (LON:RCN) Shares This Year?

First half 2021 earnings released: EPS UK£0.014

End of Formal Sale Process and Starts Discussions with Interested Parties

New 90-day low: UK£1.23

New 90-day low: UK£1.26

Redcentric plc to Report First Half, 2021 Results on Nov 17, 2020

Price target raised to UK£1.83

Insider recently sold UK£117.4k worth of stock

New 90-day high - UK£1.55

Full year earnings released - UK£0.071 loss per share

New 90-day high - UK£1.53

Redcentric plc to Report Fiscal Year 2020 Final Results on Aug 11, 2020

New 90-day high - UK£1.32

Redcentric plc has completed a Follow-on Equity Offering in the amount of £5.775 million.

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane